Wednesday, August 26, 2020 5:27:46 PM
WOW!! This is blowing up!! Please note that NeuroRx and Clinigen are receiving a high volume of requests of RLF-100 and we are working expeditiously to address these.
Due to the volume of requests of RLF-100, NeuroRx is unable to reply to voice mail messages on our system. OMG!!! Why we don't see $3+!!
Due to the volume of requests of RLF-100, NeuroRx is unable to reply to voice mail messages on our system. OMG!!! Why we don't see $3+!!
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
